Catherine S Forster1, Jichuan Wang2,3. 1. Department of Pediatrics, Children's National Health System, 111 Michigan Ave NW, Suite 4800M, Washington, DC, 20010, USA. csforster@childrensnational.org. 2. Department of Epidemiology and Biostatistics, George Washington University, Washington, DC, USA. 3. Division of Biostatistics and Study Methodology, Children's National Health System, Washington, DC, USA.
Abstract
BACKGROUND: Accurately diagnosing urinary tract infections (UTI) in children with neuropathic bladders can be difficult given the lack of specificity of both clinical symptoms and routine screening tests. We aimed to identify a priori unknown classes/groups of children with neuropathic bladder with respect to symptoms and UA results and examine their relationships with odds of UTI. METHODS: We used latent class analysis (LCA) to identify unobserved classes/groups of children with neuropathic bladder based on symptoms and urinalysis (UA) results, respectively. Demographic and clinical data were gathered by retrospective chart review of a cohort with neuropathic bladder. Symptoms and UA results were obtained by chart review of visits where urine culture was ordered. RESULTS: Around 193 patients were included in UA results analysis and 179 in symptom-based analysis. Two latent classes of patients were identified with respect to symptoms, labeled "pyelonephritis class" and "cystitis class," and two, with respect to UA results, were labeled "positive UA class" and "negative UA class." The pyelonephritis class had significantly higher odds of UTI compared to the asymptomatic class. While odds of UTI in cystitis class were higher than the asymptomatic class, this difference was not statistically significant. Positive UA class had significantly higher odds of UTI compared to negative UA class. CONCLUSION: Two unobserved classes/groups exist in children with neuropathic bladder with respect to symptoms, corresponding to cystitis and pyelonephritis, and two classes of UA results that correspond with either a positive or negative UA. Our results suggest a differential approach to treatments may be considered.
BACKGROUND: Accurately diagnosing urinary tract infections (UTI) in children with neuropathic bladders can be difficult given the lack of specificity of both clinical symptoms and routine screening tests. We aimed to identify a priori unknown classes/groups of children with neuropathic bladder with respect to symptoms and UA results and examine their relationships with odds of UTI. METHODS: We used latent class analysis (LCA) to identify unobserved classes/groups of children with neuropathic bladder based on symptoms and urinalysis (UA) results, respectively. Demographic and clinical data were gathered by retrospective chart review of a cohort with neuropathic bladder. Symptoms and UA results were obtained by chart review of visits where urine culture was ordered. RESULTS: Around 193 patients were included in UA results analysis and 179 in symptom-based analysis. Two latent classes of patients were identified with respect to symptoms, labeled "pyelonephritis class" and "cystitis class," and two, with respect to UA results, were labeled "positive UA class" and "negative UA class." The pyelonephritis class had significantly higher odds of UTI compared to the asymptomatic class. While odds of UTI in cystitis class were higher than the asymptomatic class, this difference was not statistically significant. Positive UA class had significantly higher odds of UTI compared to negative UA class. CONCLUSION: Two unobserved classes/groups exist in children with neuropathic bladder with respect to symptoms, corresponding to cystitis and pyelonephritis, and two classes of UA results that correspond with either a positive or negative UA. Our results suggest a differential approach to treatments may be considered.
Entities:
Keywords:
Cystitis; Neuropathic bladder; Pediatrics; Pyelonephritis; UTI
Authors: Caroline Roduit; Remo Frei; Martin Depner; Anne M Karvonen; Harald Renz; Charlotte Braun-Fahrländer; Elisabeth Schmausser-Hechfellner; Juha Pekkanen; Josef Riedler; Jean-Charles Dalphin; Erika von Mutius; Roger Pascal Lauener; Anne Hyvärinen; Pirkka Kirjavainen; Sami Remes; Marjut Roponen; Marie-Laure Dalphin; Vincent Kaulek; Markus Ege; Jon Genuneit; Sabina Illi; Micahel Kabesch; Bianca Schaub; Petra Ina Pfefferle; Gert Doekes Journal: JAMA Pediatr Date: 2017-07-01 Impact factor: 16.193
Authors: Alexander J Hose; Martin Depner; Sabina Illi; Susanne Lau; Thomas Keil; Ulrich Wahn; Oliver Fuchs; Petra Ina Pfefferle; Elisabeth Schmaußer-Hechfellner; Jon Genuneit; Roger Lauener; Anne M Karvonen; Caroline Roduit; Jean-Charles Dalphin; Josef Riedler; Juha Pekkanen; Erika von Mutius; Markus J Ege Journal: J Allergy Clin Immunol Date: 2016-10-19 Impact factor: 10.793
Authors: Ramiro Jose Madden-Fuentes; Erin Rebekah McNamara; Jessica Catherine Lloyd; John Samuel Wiener; Jonathan Charles Routh; Patrick Casey Seed; Sherry Sedberry Ross Journal: Pediatrics Date: 2013-07 Impact factor: 7.124
Authors: Suzanne L Groah; Marcos Pérez-Losada; Ljubica Caldovic; Inger H Ljungberg; Bruce M Sprague; Eduardo Castro-Nallar; Neel J Chandel; Michael H Hsieh; Hans G Pohl Journal: J Urol Date: 2016-01-22 Impact factor: 7.450